Murtaza Imtiyaz, Marra Giancarlo, Schlapbach Ralph, Patrignani Andrea, Künzli Marzana, Wagner Ulrich, Sabates Jacob, Dutt Amit
Biochemistry and Molecular Biotechnology Laboratory, Division of PHT, SK University of Agricultural Sciences and Technology, Shalimar Campus, Srinagar, Kashmir, India.
Biotechnol Appl Biochem. 2006 Jul;45(Pt 1):29-36. doi: 10.1042/BA20060044.
The role of the natural dietary flavonoid chemical quercetin (an antioxidant) in the prevention and treatment of colon cancer is receiving a great deal of attention. However, little is known about the molecular mechanisms of action of this flavonoid. In the present study, whole genome DNA microarrays were used to evaluate the effect of quercetin on gene expression in the CO115 colon-adenocarcinoma cell line with the completely deleted chromosome 18 harbouring the SMAD4 tumour-suppressor gene related to colon carcinogenesis. The study demonstrated that quercetin, widely present in fruit and vegetables, inhibited the growth of CO115 cells at 100 microM concentration in both the G(1)/S and the G(2)/M phases by modulating cell-cycle and apoptosis-related genes. Differential changes in accumulation of transcripts analysed for cells treated with 100 microM quercetin for 24 and 48 h in three independent repeated experiments revealed 5060-7000 differentially expressed genes. This means that quercetin probably does have a broad modulatory effect on gene expression in colon cancer. Out of these differentially expressed genes, the expression of 35 and 23 unique set of genes involved in cell-cycle control, apoptosis and xenobiotic metabolism were significantly altered after 24 and 48 h quercetin treatment respectively. Our results represent a novel aspect of the biological profile of quercetin that induces cell-cycle arrest through modulation of cell-cycle-related and apoptosis genes. The present study demonstrates a new step in elucidating the underlying molecular mechanisms of the antitumour action of quercetin, which could become a chemopreventive or chemotherapeutic agent for colon cancer.
天然膳食类黄酮化合物槲皮素(一种抗氧化剂)在结肠癌预防和治疗中的作用正受到广泛关注。然而,关于这种类黄酮的分子作用机制却知之甚少。在本研究中,利用全基因组DNA微阵列评估槲皮素对CO115结肠腺癌细胞系基因表达的影响,该细胞系18号染色体完全缺失,其中包含与结肠癌发生相关的SMAD4肿瘤抑制基因。研究表明,广泛存在于水果和蔬菜中的槲皮素,在100微摩尔浓度时通过调节细胞周期和凋亡相关基因,在G(1)/S期和G(2)/M期抑制CO115细胞生长。在三个独立重复实验中,对用100微摩尔槲皮素处理24小时和48小时的细胞分析转录本积累的差异变化,发现有5060 - 7000个差异表达基因。这意味着槲皮素可能对结肠癌基因表达具有广泛的调节作用。在这些差异表达基因中,分别在槲皮素处理24小时和48小时后,参与细胞周期控制、凋亡和外源性物质代谢的35个和23个独特基因集的表达发生了显著改变。我们的结果代表了槲皮素生物学特性的一个新方面,即通过调节细胞周期相关基因和凋亡基因诱导细胞周期停滞。本研究为阐明槲皮素抗肿瘤作用的潜在分子机制迈出了新的一步,槲皮素有望成为结肠癌的化学预防或化学治疗药物。